Parkin-associated endothelin receptor-like receptor (Pael-R) is a G protein-coupled receptor (GPCR) implicated in various cellular processes, including cell signaling, regulation of endocytosis, and intracellular trafficking. Pael-R's function within the cellular milieu is complex, given its role in mediating responses to extracellular signals through its interaction with G proteins, which subsequently trigger multiple downstream signaling pathways. These pathways are critical for maintaining cellular homeostasis, mediating cellular responses to stress, and regulating cell survival and apoptosis. The activation of Pael-R involves its binding to specific ligands, which induces a conformational change in the receptor, enabling it to interact with and activate heterotrimeric G proteins. This interaction leads to the dissociation of the G protein into its Gα and Gβγ subunits, both of which can activate various intracellular signaling cascades, including the activation of adenylyl cyclase, modulation of ion channels, and regulation of phospholipase C activity.
The mechanisms of Pael-R activation are multifaceted and highly regulated, involving not only the direct binding of ligands but also the receptor's interaction with regulatory proteins and its localization within the cell membrane. Post-translational modifications, such as phosphorylation, play a significant role in regulating Pael-R's activity, affecting its ligand affinity, G protein coupling efficiency, and susceptibility to internalization and degradation. Additionally, the cellular context, including the presence of specific G protein subtypes and regulatory proteins, can significantly influence Pael-R's signaling outcomes, leading to diverse physiological effects. The specificity of signaling pathways activated by Pael-R is further modulated by the spatial and temporal dynamics of receptor and G protein interactions, with scaffolding proteins and regulatory factors guiding the formation of signaling complexes at specific cellular locations. This intricate regulation of Pael-R activation underscores its versatility as a signaling receptor capable of mediating a wide range of cellular responses to external and internal cues, highlighting its importance in cellular physiology and homeostasis.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Levodopa | 59-92-7 | sc-205372 sc-205372A | 5 g 25 g | $54.00 $171.00 | 9 | |
Precursor to dopamine, with the potential for direct activation of Pael-R due to its role in increasing dopamine levels. | ||||||
Bromocriptine | 25614-03-3 | sc-337602A sc-337602B sc-337602 | 10 mg 100 mg 1 g | $57.00 $265.00 $567.00 | 4 | |
A dopamine receptor agonist that can indirectly activate Pael-R by stimulating dopamine receptors. | ||||||
Bosentan | 147536-97-8 | sc-210957 | 10 mg | $195.00 | 3 | |
As an endothelin receptor antagonist, Bosentan may indirectly influence Pael-R by modulating endothelin-1 signaling. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
A phosphodiesterase inhibitor that can indirectly activate Pael-R by preventing cAMP breakdown, affecting cAMP-mediated pathways. | ||||||
N-Acetyl-L-cysteine | 616-91-1 | sc-202232 sc-202232A sc-202232C sc-202232B | 5 g 25 g 1 kg 100 g | $34.00 $74.00 $270.00 $114.00 | 34 | |
An antioxidant with the potential for indirect activation of Pael-R by reducing oxidative stress associated with neurodegenerative conditions. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
An anti-inflammatory compound with indirect potential to influence Pael-R by reducing neuroinflammation in the context of neurodegenerative diseases. | ||||||
Memantine hydrochloride | 41100-52-1 | sc-203628 | 50 mg | $69.00 | 4 | |
An NMDA receptor antagonist, indirectly influencing Pael-R by modulating glutamate-related pathways and excitotoxicity. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
A PKC activator that may indirectly influence Pael-R by stimulating PKC-mediated signaling pathways. | ||||||